Liver fibrotic development is reduced through inflammation prevention by an adenosine derivative compound

Background: Liver fibrosis is a global health problem, and studying its development provides important information to address its treatment. Here, we characterized the effects of an adenosine compound (IFC-305) on preventing fibrosis and liver inflammation. Methods: We studied the impact of IFC-305...

Full description

Bibliographic Details
Main Authors: Mariana Domínguez-López, Rebeca Pérez-Cabeza de Vaca, Jesús Rafael Rodríguez-Aguilera, Nuria Guerrero-Celis, Gabriela Velasco-Loyden, Victoria Chagoya de Sánchez
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223010077